Carregant...
Inhibition of RAS: proven and potential vulnerabilities
RAS is a membrane localized small GTPase frequently mutated in human cancer. As such, RAS has been a focal target for developing cancer therapeutics since its discovery nearly four decades ago. However, efforts to directly target RAS have been challenging due to the apparent lack of readily discerna...
Guardat en:
| Publicat a: | Biochem Soc Trans |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7875515/ https://ncbi.nlm.nih.gov/pubmed/32869838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BST20190023 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|